Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Masayuki Mita"'
Autor:
Masayuki Mita, Tsutomu Shichishima, Hideyoshi Noji, Hiroshi Takahashi, Ken-Ichi Nakamura, Takayuki Ikezoe
Publikováno v:
HemaSphere, Vol 2, Iss 5, p e142 (2018)
Externí odkaz:
https://doaj.org/article/6340cbdad2164b429d5d6b02a4421d97
Publikováno v:
Case Reports in Hematology, Vol 2014 (2014)
In the past decade, the serum free light chain (FLC) immunoassays have become widely available enabling greater sensitivity in the diagnosis and management of monoclonal light chain diseases. Here, we describe a rare case of serum free light chain on
Externí odkaz:
https://doaj.org/article/c5d3e36ab509403c892e536ca5e9d04c
Autor:
Jun Imagawa, Yoshiaki Chinen, Toru Kiguchi, Chisaki Mizumoto, Katsumichi Fujimaki, Toshihiro Fukushima, Masayuki Mita, Kazunori Murai, Satoshi Wakita, Takayuki Ikezoe, Satoshi Kimura, Chikashi Yoshida, Takaaki Ono, Takeshi Kondo, Atsushi Kawaguchi, Junichi Sakamoto, Ayako Takamori, Jun Aoki, Katsuhiro Io, Kaori Karimata, Yasufumi Matsuda, Kaichi Nishiwaki, Kensuke Usuki, Hirohiko Shibayama, Joji Shimono, Takashi Kumagai, Tomoharu Takeoka, Junya Kuroda, Shinya Kimura, Masatomo Miura, Kensuke Nakao, Yousuke Minami, Nobuhiko Uoshima, Hiroshi Ureshino, Koiti Inokuchi, Hideo Tanaka
Publikováno v:
The Lancet. Haematology. 8(12)
Summary Background BCR-ABL1 tyrosine kinase inhibitors (TKIs) are commonly initiated in older patients with chronic myeloid leukaemia in the chronic phase at standard doses. However, because of their safety profile in this population, appropriate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8e609cd0305848ad101ef873748a2dc
https://pubmed.ncbi.nlm.nih.gov/34826413
https://pubmed.ncbi.nlm.nih.gov/34826413
Autor:
Masatsugu Ohta, Masumi Sukegawa, Hirotaka Mori, Satoshi Kimura, Takahiro Sano, Masayuki Mita, Tomiyoshi Saito, Ken-ichi Nakamura, Takayuki Ikezoe, Kayo Harada, Masahiko Fukatsu, Hiroshi Ohkawara, Yoichi Hamazaki, Hiroshi Takahashi
Publikováno v:
Annals of Hematology. 99:359-361
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73547def8b5396d637433969482175d1
https://doi.org/10.1007/s00277-019-03896-4
https://doi.org/10.1007/s00277-019-03896-4
Autor:
Nobuhiko Uoshima, Masayuki Mita, Chisaki Mizumoto, Hiroshi Ureshino, Satoshi Wakita, Hirohiko Shibayama, Koiti Inokuchi, Satoshi Kimura, Kaori Karimata, Kensuke Nakao, Joji Shimono, Toru Kiguchi, Kaichi Nishiwaki, Hideo Tanaka, Katsumichi Fujimaki, Takayuki Ikezoe, Katsuhiro Io, Takashi Kumagai, Toshihiro Fukushima, Atsushi Kawaguchi, Yoshiaki Chinen, Yasufumi Matsuda, Ayako Takamori, Kazunori Murai, Jun Aoki, Yosuke Minami, Takaaki Ono, Takeshi Kondo, Chikashi Yoshida, Junya Kuroda, Junichi Sakamoto, Tomoharu Takeoka, Shinya Kimura, Masatomo Miura, Kensuke Usuki, Jun Imagawa
Publikováno v:
Blood. 138:3601-3601
Introduction: Tyrosine kinase inhibitors (TKIs) dramatically improved the prognosis of chronic myelogenous leukemia (CML), as nearly half of CML patients presenting with a deep molecular response (DMR) over several years could achieve treatment-free
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c38884d0460be847bad457c47eec50c
https://doi.org/10.1182/blood-2021-149483
https://doi.org/10.1182/blood-2021-149483
Autor:
Takayuki Ikezoe, Hiroshi Takahashi, Tsutomu Shichishima, Hideyoshi Noji, Masayuki Mita, Ken-ichi Nakamura
Publikováno v:
HemaSphere, Vol 2, Iss 5, p e142 (2018)
Hemasphere
Hemasphere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::584c6ea3fe93512c1255c3a052c34543
http://journals.lww.com/10.1097/HS9.0000000000000142
http://journals.lww.com/10.1097/HS9.0000000000000142
Autor:
Masumi Sukegawa, Masatoshi Okamoto, Bin Pan, Hiromi Shimura, Masayuki Mita, Hiroshi Ohkawara, Chie Nishioka, Masatsugu Ohta, Ken-ichi Nakamura, Xiangmin Wang, Takayuki Ikezoe, Yoichi Hamasaki, Kailin Xu
Publikováno v:
Leukemia research. 58
BCR/ABL tyrosine kinase inhibitors (TKIs) have significantly improved the prognosis for in dividuals with chronic myeloid leukemia (CML). However, many patients treated with TKIs suffer from TKI-related complications. In particular, vascular events s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b62b4a4da12fbc6a1e99571c517b519d
https://pubmed.ncbi.nlm.nih.gov/28501737
https://pubmed.ncbi.nlm.nih.gov/28501737
Publikováno v:
FUKUSHIMA JOURNAL OF MEDICAL SCIENCE. 48:57-62
Chlamydia pneumoniae (C. pneumoniae) is a common pathogen of community-acquired pneumonia. The clinical features of infection caused by C. pneumoniae are usually mild and it does not progress into respiratory failure in young people. We describe a he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bfabdd24c2c155ac421c291d87eb7b9
https://doi.org/10.5387/fms.48.57
https://doi.org/10.5387/fms.48.57
Publikováno v:
Case Reports in Hematology, Vol 2014 (2014)
Case Reports in Hematology
Case Reports in Hematology
In the past decade, the serum free light chain (FLC) immunoassays have become widely available enabling greater sensitivity in the diagnosis and management of monoclonal light chain diseases. Here, we describe a rare case of serum free light chain on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49df418f3c9041cce105687e11de3ab0
https://doaj.org/article/c5d3e36ab509403c892e536ca5e9d04c
https://doaj.org/article/c5d3e36ab509403c892e536ca5e9d04c
Publikováno v:
Hematology and Leukemia. 4:3
Pure erythroid leukemia (PEL) is characterized as a neoplastic erythroid hyperproliferation with maturation arrest, showing highly complex karyotypes, prominent clonal evolution, and a very aggressive clinical course. Here, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b995c8308f80c878a0250cf55909c75f
https://doi.org/10.7243/2052-434x-4-3
https://doi.org/10.7243/2052-434x-4-3